A phase I clinical trial utilizing autologous tumor-infiltrating lymphocytes in patients with primary hepatocellular carcinoma

This report describes an ongoing Phase I clinical trial testing the safety of adoptive cell therapy (ACT) using autologous tumor-infiltrating lymphocytes (TIL) in patients with primary hepatocellular carcinoma (HCC). Fifteen HCC patients were treated with their activated and expanded TILs following...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Oncotarget
Asıl Yazarlar: Jiang, Shan-Shan, Tang, Yan, Zhang, Yao-Jun, Weng, De-Sheng, Zhou, Zhong-Guo, Pan, Ke, Pan, Qiu-Zhong, Wang, Qi-Jing, Liu, Qing, He, Jia, Zhao, Jing-Jing, Li, Jiang, Chen, Min-Shan, Chang, Alfred E., Li, Qiao, Xia, Jian-Chuan
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Impact Journals LLC 2015
Konular:
Clinical Research Paper
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4747409/
https://ncbi.nlm.nih.gov/pubmed/26515587
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller